article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S In 2017, Congress acted again to update the Common Rule and strengthen the provisions related to consent. While the U.S. These warnings echo those of the U.S.

article thumbnail

Part 3: An Update on the Federal and State E-Roe-sion or P-Roe-tection of Abortion Rights

Healthcare Law Blog

The bill amends the existing Women’s Right to Know Act with the expansion of the definition of abortion. The information included in this article is current as of August 1, 2023, but it does not address all potential legal issues or jurisdictional differences, and the information presented may no longer be current. [1]

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Addresses the Role of Digital Health Technology in Clinical Trials

Healthcare Law Today

Food & Drug Administration (FDA) recently issued draft guidance regarding the use of digital health technology (DHT) for the remote acquisition of clinical trial data. The FDA, however, does not regulate all DHT products because the products do not always meet the definition of a medical device, e.g., a general wellness device.

FDA 52
article thumbnail

Malarkey ? The Ten Worst Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

FDA , 78 F.4th 2023), was the Fifth Circuit’s blatantly politicized attack on the FDA’s regulation of abortion-related drugs. The questionable allegations of that single complaint thus effectively trumped many years of the FDA’s science-based decision-making. The FDA, for one, advised patients to keep using these drugs.

FDA 52
article thumbnail

Suing the Certifiers – A Dangerous Undertaking

Drug & Device Law

Anyway, this fraudulent “doctor” allegedly “touched them without informed consent” and caused them “emotional distress. Nor could a trade association be liable for common-law negligence in either jurisdiction: “[P]ublication of testing standards and ingredient definitions did not create any legal duty to the general public.”

Doctors 52
article thumbnail

Stupid Expert Tricks Redux

Drug & Device Law

While cosmetic talc is not a drug or medical device, the FDA also regulates it (the “C” in the FDCA). While the compensation claims did “not definitively establish” other asbestos exposure, plaintiff “nonetheless made statements. . ., 11-17 (Jan. may well be factually applicable to Dr.

article thumbnail

S.D. Texas Trims Back Mesh Plaintiff Regulatory Expert Opinions

Drug & Device Law

Speaking of clothing, sometimes plaintiff regulatory experts engage in cosplay, donning a quasi-military uniform from their service in the FDA many decades ago. This masquerade occurs despite the fact that the expert’s prior FDA position had little or nothing to do with the subject of the litigation. No Informed Consent.